0000000001312320

AUTHOR

Ana M. Rodríguez

showing 6 related works from this author

1,2-Dipolar addition model for the cytoprotective activity of selected α,β-unsaturated compounds with CO functionality: an ab initio study

2001

Abstract The mechanism of the addition of a nucleophile (an alkylthiol group) to a double bond of α,β-unsaturated systems in the gas phase was explored. In this study, intermediates of the reaction were also investigated using ab initio calculations (RHF/6-31G ∗ and MP2/6-31+G ∗ ). Our results indicate that direct dipolar attack of the S–H group of an alkylthiol on the CC double bond is a reasonable reaction path. The present results represent, therefore, additional support for our hypothesis. This suggests that the mechanism of cytoprotection might be mediated, at least in part, by a reaction between the olefinic acceptor and the sulfhydryl-containing groups of the mucosa.

chemistry.chemical_classificationDouble bondStereochemistryAb initioCondensed Matter PhysicsBiochemistryAcceptorCytoprotectionDipolechemistryNucleophileComputational chemistryAb initio quantum chemistry methodsReaction pathPhysical and Theoretical ChemistryJournal of Molecular Structure: THEOCHEM
researchProduct

Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2-Benzoazol…

2018

In this paper, the synthesis, comprehensive characterization and biological and photocatalytic properties of two series of neutral IrIII biscyclometalated complexes of general formula [Ir(C^N)2(N^O)], where the N^O ligands are 2‐(benzimidazolyl)phenolate‐N,O (L1, series a) and 2‐(benzothiazolyl)phenolate‐N,O (L2, series b), and the C^N ligands are 2‐(phenyl)pyridinate or its derivatives, are described,. Complexes of types a and b exhibit dissimilar photophysical and biological properties. In vitro cytotoxicity tests conclusively prove that derivatives of series a are harmless in the dark against SW480 cancer cells (colon adenocarcinoma), but express enhanced cytotoxicity versus the same cel…

010405 organic chemistryLigandChemistrymedicine.medical_treatmentOrganic ChemistryPhotodynamic therapy2-arylazolesphotodynamictherapyQuímicaGeneral Chemistry010402 general chemistry01 natural sciencesMedicinal chemistryanticancercomplexesCatalysis0104 chemical sciencesChemistryheterolepticneutraliridium(III)complexesmedicinephosphorescent complexesChemistry - A European Journal
researchProduct

Highly Stable and Efficient Light-Emitting Electrochemical Cells Based on Cationic Iridium Complexes Bearing Arylazole Ancillary Ligands.

2017

A series of bis-cyclometalated iridium(III) complexes of general formula [Ir(ppy)2(N∧N)][PF6] (ppy− = 2-phenylpyridinate; N∧N = 2-(1H-imidazol-2-yl)pyridine (1), 2-(2-pyridyl)benzimidazole (2), 1-methyl-2-pyridin-2-yl- 1H-benzimidazole (3), 2-(4′-thiazolyl)benzimidazole (4), 1- methyl-2-(4′-thiazolyl)benzimidazole (5)) is reported, and their use as electroluminescent materials in light-emitting electrochemical cell (LEC) devices is investigated. [2][PF6] and [3][PF6] are orange emitters with intense unstructured emission around 590 nm in acetonitrile solution. [1][PF6], [4][PF6], and [5][PF6] are green weak emitters with structured emission bands peaking around 500 nm. The different photoph…

BenzimidazoleLigandchemistry.chemical_element02 engineering and technologyQuímica analíticaElectroluminescence010402 general chemistry021001 nanoscience & nanotechnologyPhotochemistry01 natural sciences0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundCrystallographychemistryPyridineIridiumChemistry AnalyticPhysical and Theoretical ChemistryTriplet state0210 nano-technologyAcetonitrileHOMO/LUMOInorganic chemistry
researchProduct

CCDC 1857871: Experimental Crystal Structure Determination

2018

Related Article: Marta Martínez-Alonso, Natalia Busto, Larry Danilo Aguirre, Leticia Berlanga, M. Carmen Carrión, José V. Cuevas, Ana M. Rodríguez, Arancha Carbayo, Blanca R. Manzano, Enrique Ortí, Félix A. Jalón, Begoña García, Gustavo Espino|2018|Chem.-Eur.J.|24|17523|doi:10.1002/chem.201803784

[2-(1H-benzimidazol-2-yl)phenolatato]-bis[35-difluoro-2-(pyridin-2-yl)phenyl]-iridium(iii) acetone solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1519073: Experimental Crystal Structure Determination

2017

Related Article: Marta Martínez-Alonso, Jesús Cerdá, Cristina Momblona, Antonio Pertegás, José M. Junquera-Hernández, Aránzazu Heras, Ana M. Rodríguez, Gustavo Espino, Henk Bolink, and Enrique Ortí|2017|Inorg.Chem.|56|10298|doi:10.1021/acs.inorgchem.7b01167

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(2-(pyridin-2-yl)phenyl)-(2-(13-thiazol-4-yl)-1H-benzimidazole)-iridium(iii) hexafluorophosphateExperimental 3D Coordinates
researchProduct

CCDC 1519074: Experimental Crystal Structure Determination

2017

Related Article: Marta Martínez-Alonso, Jesús Cerdá, Cristina Momblona, Antonio Pertegás, José M. Junquera-Hernández, Aránzazu Heras, Ana M. Rodríguez, Gustavo Espino, Henk Bolink, and Enrique Ortí|2017|Inorg.Chem.|56|10298|doi:10.1021/acs.inorgchem.7b01167

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(1-methyl-2-(13-thiazol-4-yl)-1H-benzimidazole)-bis(2-(pyridin-2-yl)phenyl)-iridium(iii) hexafluorophosphateExperimental 3D Coordinates
researchProduct